As oral GLP-1 treatments move closer to the UK market, understanding how people emotionally respond to the idea of a weight loss tablet could offer an early indication of how these treatments may be adopted once they become available
For a plain explanation of why supplement style products are held to a different standard than approved drugs, see the United States Food and Drug Administration consumer guidance on dietary supplements, which explains why supplement style products are not tested for effectiveness before they are allowed to reach the market
Intraperitoneal glucose tolerance test (ipGTT) Ten-week-old C57BL/6 J mice (The Jackson Laboratory, Bar Harbor, ME, USA) were administered the indicated drugs (15 nmol/kg) and maintained for 24 h, prior to testing, including a 6-h fasting period immediately before the ipGTT
As with any weight loss program, it is important to consult with a healthcare provider before beginning treatment with GLP1s injections, and to continue to monitor one's health throughout the course of treatment
Been taking for about a year now